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ABSTRACT 
INTRODUCTION: 
The incidence of intraventricular hemorrhage (IVH) in very low birth weight 
infants is between 25 and 50%. Approximately 13-60% of these patients will 
develop progressive post hemorrhagic hydrocephalus (PHH) and of these 22-
70% will require CSF diversion. The most common therapeutic intervention is 
insertion of a ventriculoperitoneal shunt but there is considerable controversy 
surrounding the timing of the operation. Most authors promote early surgery to 
prevent secondary injury from hydrocephalus but it was our impression that 
this was associated with a higher incidence of shunt complications. 
METHOD: 
The incidence of shunt complications in 36 patients shunted for PHH were 
retrospectively reviewed. Patients were treated at Red Cross Children's 
Hospital over an 8 year period. 
RESULTS: 
Nine (25%) of the 36 patients required shunt revision for obstruction, seven 
required revision during the initial admission. Shunt infection occurred in 4 
patients (11 %) all during the initial hospital admission. Four patients died, one 
from a shunt related complication. There was a clear relationship between the 
timing of surgery and the incidence of complications (chi square test p,0.01 ). 
Nineteen patients underwent surgery before 5 weeks of age and 9 developed 
early shunt complications. Of those shunted after 5 weeks none had an early 
complication. Groups were matched for weight and grade of IVH. 
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DISCUSSION: 
A possible explanation for these results is that shunt complications are related 
to the quantity of blood present in the CSF at the time of shunting. A short 
delay before intervention is recommended in an effort to reduce the morbidity 
of shunt complications. 
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CHAPTER 1: INTRODUCTION 
The management of post-haemorrhagic hydrocephalus in the premature 
infant remains a controversial topic in Paediatric Neurosurgery. Numerous 
therapeutic options are described ranging from conservative treatment to 
early ventriculo-peritoneal shunting 48• 64• 68. There are many reasons for this 
variety of options. This is a group of patients in whom the incidence of serious 
complications is high and neurological outcome often disappointing. This in 
turn translates to high costs, both in terms of money and hours spent caring 
for these children by their families and medical staff. The range of therapeutic 
options therefore reflects medical opinion and resources at various centers. 
Some feel that the outcome in this group of patients does not warrant the cost 
and effort involved 52 , while others feel that intensive active therapy may lead 
to improved, worthwhile outcome making the cost justifiable 3. In between 
these two divergent opinions and actions lie many other therapeutic protocols. 
The Red Cross War Memorial Children's Hospital in Cape Town is a referral 
center for Paediatric Neurosurgery where a significant number of patients 
with post-haemorrhagic hydrocephalus are treated. When managing these 
patients we face the same problems as other Paediatric Neurosurgery 
Institutions, but must also take into account that they are often from a poor 
background. The burden of caring for a disabled child is felt more acutely in 
these circumstances and for this reason we have examined ways of limiting 
complications without compromising neurological outcome. This dissertation 
consists of a literature review looking at the pathophysiology, management 
and outcome of intraventricular haemorrhage (IVH) and post-haemorrhagic 
hydrocephalus (PHH) in low birth weight infants. This provides the 
background to a retrospective study of the treatment of PHH at Red Cross 
Children's Hospital over an eight-year period. The findings of the study are 
discussed in the context of accepted therapeutic protocols and what is 
appropriate for our environment. 
DEFINITIONS 
On review of the current literature it is apparent that many terms are used 
interchangeably so it is appropriate to define the terms that are to be used in 
this dissertation. 
LOW BIRTH WEIGHT INFANT 
By international consensus all infants with a birth weight of 2500g or less are 
considered low birth weight. This may either be as a result of prematurity or 
growth retardation or a combination of these factors. Very low birth weight 
(VLBW) refers to infants under 1500g. 
PRETERMINFANT 
Any infant born before completing 37 weeks in utero is preterm. 
lntraventricular haemorrhage is associated with prematurity but in the vast 
majority occurs only when birth is before 32 weeks. At this gestational age 
birth weight is usually below 2500 grams. It is for this reason that this study 
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refers to IVH in low birth weight infants. In the retrospective study done at Red 
Cross Hospital the gestational age was not always accurately known. 
INTRA VENTRICULAR HAEMORRHAGE 
lntraventricular haemorrhage is a pathological term used to describe a 
combination of periventricular and intraventricular haemorrhage that occurs in 
some preterm infants. Various grading systems have been described based 
on the extent of parenchymal destruction and the amount of haemorrhage in 
the ventricular system. When not referring to a particular grading system it is 
better to use the term periventricular haemorrhage to describe haemorrhage 
that has not extended into the ventricles. IVH is the most common variety of 
neonatal intracranial haemorrhage and its importance relates to its high 
incidence and the gravity of the more severe forms with their attendant 
complications. 
POST-HAEMORRHAGIC HYDROCEPHALUS 
Post-haemorrhagic hydrocephalus can be defined as progressive dilation of 
the ventricular system that develops as a complication of neonatal 
intraventricular haemorrhage 25. It does not include hydrocephalus caused by 
other forms of intracranial haemorrhage occurring in the new-born child. This 
definition implies that continuing ventricular enlargement will result in clinical 
signs, necessitating treatment of the hydrocephalus. 
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INCIDENCE 
The incidence of IVH has decreased over the past decade with improvements 
in both obstetric and neonatal intensive care. Recently reported series 
indicate an incidence of between 21-50% in premature infants 18· 19· 22· 33· 52· 73 . 
Some of the variability is accounted for by the differing maximum weight 
allowed as an exclusion criteria in these studies. The incidence of IVH is 
higher in very low birth weight infants and has been reported to be as high as 
90% 5. This decrease in the incidence of IVH is demonstrated by a report from 
the Washington University School of Medicine; the incidence of IVH in 
neonates less than 2000 grams in the early 1980's was 39%, this dropped to 
25% at the end of the decade 73 . 
It is unfortunate that this decrease has not translated into fewer patients with 
IVH in all centers. In sophisticated health care environments survival rates for 
premature infants, particularly those who weigh less than 1000 grams, 
continue to increase. With the higher incidence of IVH in this group it 
continues to be a problem in the neonatal intensive care unit. 
The incidence of PHH is difficult to ascertain, as there is no accepted grading 
system that will allow for comparison between different published series. For 
this reason the diagnosis of PHH is subjective. Filling of the ventricular system 
with blood in the higher grades of IVH results in ventricular enlargement. As a 
rule this is not referred to as PHH. The diagnosis is usually made after serial 
transcranial ultrasound or CT scan shows progressive ventricular dilatation. 
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Following the development of progressive ventriculomegaly, approximately 
50% of cases spontaneously arrest within a month, with partial or total 
resolution of the ventriculomegaly. In the remaining 50% the ventricular size 
increases progressively for more than a month and is accompanied by raised 
intracranial pressure requiring treatment 72.The reported incidence of PHH in 
series where patients have been followed up over some time is between 13-
60% and of these patients between 22% and 70% have received permanent 
cerebrospinal fluid (CSF) diversion with a shunt 3• 16· 18· 32 · 39 · 49 · 54· 63 . The 
variation in the percentage of shunted patients may be due to the different 
therapeutic regimens these patients were subjected to. In the majority of 
patients the progression of PHH seems to be slow and predictable however in 
a small percentage of patients the ventricular enlargement is rapid requiring 
more urgent treatment 76 . 
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CHAPTER 2: PATHOPHYSIOLOGY OF 
INTRAVENTRICULAR HAEMORRHAGE AND 
POST-HAEMORRHAGIC HYDROCEPHALUS 
PATHOGENESIS OF INTRAVENTRICULAR HAEMORRHAGE 
The site of origin of IVH is the subependymal germinal matrix. This is an area 
immediately ventrolateral to the lateral ventricle and between 10 and 20 
weeks contains cerebral neuroblast cells. In the third trimester of pregnancy 
these cells mature into glioblasts which will become oligodendrocytes and 
astrocytes. It is also an area that contains many thin walled vessels that are 
the source of bleeding in IVH. The site of haemorrhage within the matrix 
varies with gestational age 20. In infants less than 28 weeks gestation bleeding 
occurs in the matrix overlying the caudate nucleus body. In infants between 
28 and 32 weeks gestation the lesion is at the head of the caudate nucleus. 
After 32 weeks haemorrhage is more likely to occur from the choroid plexus. 
The majority of haemorrhages occur in the first few days of life, with 
approximately one third of the haemorrhages developing within the first hour 
of age. Risk factors can either be maternal, such as cocaine use 65, or they 
can be neonatal. Perinatal and postnatal factors such as, labour, delivery and 
respiratory distress are considered contributory to the process 52 . These 
events either alone or together act in the premature neonate to produce IVH 
through intravascular, vascular or extravascular pathologies 73 . 
INTRAVASCULAR FACTORS 
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It appears that the regulation of cerebral blood flow and pressure in the 
neonate is easily disturbed if the birth is premature and the child is exposed to 
complications such as respiratory distress. Factors that relate to platelet-
capillary function and blood clotting may contribute but are of less importance. 
Fluctuation of cerebral blood flow 
Two patterns of cerebral blood flow are observed in patients ventilated for 
respiratory distress of prematurity. A stable pattern is associated with systolic 
and diastolic blood flow velocities that are constant where as in an unstable 
pattern both velocities vary. Patients with an unstable cerebral blood flow are 
far more likely to develop IVH 50. The cause of the fluctuation is mechanical 
ventilation that is not synchronised with the patients breathing and this may be 
improved by inducing muscle paralysis. 
Increase and decrease in cerebral blood flow 
In experimental animal models IVH is provoked most readily by a sequence of 
hypotension followed by hypertension. It appears that autoregulation in the 
premature child is abnormal for a variety of reasons such as vessel dilatation 
due to hypoxia (protective shunting of blood from the gut to the foetal brain 
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occurs) or hypercarbia and cranial trauma. This leads to a pressure passive 
cerebral circulation with a change in arterial pressure being mirrored by a 
change in flow. A drop in cerebral blood flow may lead to ischaemic changes 
in a vascular border zone in the germinal matrix, or cause injury to vessels in 
this area. If flow then increases, bleeding may occur either because of poor 
vessel integrity or germinal matrix reperfusion injury. Increased cerebral blood 
pressure or flow may be caused by a number of factors. Hypercarbia is a 
common accompaniment of respiratory distress syndrome and is a potent 
vasodilator. Decreased haematocrit has also been shown to significantly 
increase cerebral blood flow in an autoregulatory effort to increase oxygen 
delivery to the brain. A low haematocrit is a common finding in sick premature 
infants due to iatrogenic blood loss and low initial blood volume. Abrupt 
elevations of blood pressure may also be brought about by noxious stimuli 
such as exchange transfusion, pneumothorax and tracheal suctioning. 
Increases in cerebral venous pressure 
Perfusion pressure in capillary beds is partly dependent on venous pressure. 
If uncontrolled rapid changes in venous pressure occur perfusion pressure will 
also change without time for the protective effects of autoregulation to occur. 
The germinal matrix is particularly prone to the effects of venous pressure as 
this is an area of venous confluence. The medullary, thalamostriate and 
choroidal veins unite in the subependymal tissue of the lateral ventricle at the 
level of the foramen of Monro. This is the most common site of germinal 
matrix haemorrhage. There can be many causes of raised venous pressure in 
premature infants such as labour and delivery, asphyxia and respiratory 
complications. 
Platelet and coagulation disturbance 
Disturbances of coagulation are common in premature infants with 
complications of asphyxia and respiratory distress. It is therefore difficult to 
establish if coagulopathy has an independent pathogenic role in the 
development of IVH. 
VASCULAR FACTORS 
Tenuous capillary integrity 
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Capillary vessels in the germinal matrix are in the process of involution. As the 
germinal matrix disappears with cell migration the immature micro-vasculature 
remodels into a mature capillary bed. These immature vessels are also larger 
than normal capillaries, composed only of an endothelial layer. It is likely that 
these changing vessels are more susceptible to rupture and haemorrhage. 
Vulnerability to hypoxic-ischaemic injury 
The germinal matrix contains a vascular border zone between striate and 
thalamic vessels. This area is likely to be susceptible to hypoxia in the event 
of reduced cerebral blood flow. As these capillary endothelial cells also have a 
high requirement for oxidative metabolism, injury to the vessel wall could 
easily occur. 
12 
EXTRAVASCULARFACTORS 
Deficient vascular support 
The germinal matrix provides poor support for the large walled capilliaries that 
pass through it because it is nearly devoid of mesenchymal elements. 
Unsupported vessels are more likely to rupture. 
Fibrinolytic Activity 
Increased fibrinolysis is characteristic of remodeling systems and would 
predispose to haemorrhage in this area. 
PROGRESSION OF INTRAVENTRICULAR HAEMORRHAGE 
Various factors after birth may contribute to the enlargement and extension of 
a germinal matrix haemorrhage. Seizure activity, pneumothorax development, 
volume overload, hypoxia, acidosis, hypercarbia and other disturbances which 
result in increased cerebral blood flow have all been shown to exacerbate the 
lesion 41 . In the study by Shankaran et al 10% of 62 patients with IVH had 
significant progression of the haemorrhage during the first 2 weeks of life 63 . 
For this reason it is important that the final grading of IVH is delayed until 2 
weeks after birth as this will ultimately help determine prognosis. 
PATHOGENESIS OF POST-HAEMORRHAGIC 
HYDROCEPHALUS 
According to Oi there are three pathophysiological aspects to the 
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development of hydrocephalus in the premature child 44 . The first is 
underdevelopment of major CSF pathways. The second is extremely high 
intracranial compliance and finally the brain is still undergoing myelination. For 
these reasons the premature brain is susceptible to developing hydrocephalus 
after an insult such as IVH. The soft, unmyelinated brain also allows 
significant ventricular dilatation to occur without any increase in head size. 
This is illustrated in a study by Levene and Starke who in a longitudinal study 
of ventricular dilation after IVH found a group of patients who had persistent 
ventricular dilation but normal head growth over 52 weeks 32 . 
Prior to the mid 1970's, PHH was thought to be an inevitable occurrence in 
infants who survived IVH 30 . This is certainly not the case but assessment of 
the true incidence of PHH is difficult to ascertain. As has been mentioned 
previously diagnostic criteria for PHH differ from study to study and the natural 
history is often obscured by early therapeutic intervention. Selection bias also 
plays a role as many centres are referred only the severe grades of IVH. In 
the longitudinal follow up of 68 patients with IVH by Levene and Starke 31 % 
showed some degree of ventricular dilation but only 8% of surviving patients 
were ultimately shunted 32. Similar results have been shown in other studies 
where therapeutic intervention has been relatively late 16· 22· 63. 
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There is a strong correlation between the severity of IVH and the probability of 
developing hydrocephalus 3· 6· 22· 46 · 54· 62· 63 . Most severe grades of IVH start 
with some degree of ventricular enlargement caused by distension of the 
ventricular system by blood at the time of haemorrhage 63 . This ventricular 
dilation does not progress in all cases, in some regression will occur and in 
others stabilisation. Blood in the ventricular system rapidly reaches the 
subarachnoid space and it is postulated that clots may block CSF pathways 
20
. Possible sites of obstruction include the aqueduct, V4 outflow foramina, the 
tentorial orifice and the arachnoid granulations 30· 35 . This obstruction to CSF 
flow and absorption would account for the early development hydrocephalus. 
It may also provide a reason for the spontaneous resolution of hydrocephalus 
in some patients. As blood products and debris clear from the ventricle, 
normal CSF pathways may re-open allowing regression of ventricular 
enlargement. Liquefaction of a clot in the ventricular system may take 10 days 
or more 35 . 
Other mechanisms may account for the persistence of hydrocephalus or the 
development of delayed hydrocephalus. Fibrosing arachnoiditis in response to 
haemorrhage has been demonstrated in some patients 30· 73 . It is thought that 
the presence of blood products and cellular debris initiates a chemical 
meningitis, particularly in the posterior fossa. The posterior fossa may be 
more affected as this is where blood tends to collect after IVH 73 . Resolution of 
the inflammatory process leads to a fibrous thickening of the meninges with 
obstruction to CSF flow through the subarachnoid space. This process could 
also account for the hydrocephalus that develops in infants with less severe 
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IVH as only a small amount of haemorrhage would be required 73. It is likely 
though that multiple pathogenic mechanisms account for the hydrocephalus 
seen after IVH. The differing sites of CSF obstruction that can be inferred from 
a CT scan illustrate this. In the study by Shankaran et al only 15% of patients 
with hydrocephalus had enlargement of the third and fourth ventricles caused 
by obliterative arachnoiditis. This would imply that all other patients had 
obstruction to CSF flow within the ventricular system even after resolution of 
intra-ventricular clot 63 . Ependymal disruption and reactive sub-ependymal 
gliosis may also play a role in the development of delayed hydrocephalus 73 . 
The interval between IVH and the onset of progressive ventricular dilation 
varies. In severe IVH dilation has been recorded between day 1 and day 40, 
in most however dilation starts within the first 2 weeks after IVH 32· 49. Delayed 
hydrocephalus after IVH has been reported by Perlman 49. Of 193 patients 
with IVH, 4 developed hydrocephalus between 5-12 months after the initial 
haemorrhage. Three of these patients had minor haemorrhages. If 
spontaneous resolution of hydrocephalus occurs it usually takes place around 
the end of the first month after diagnosis of IVH 32• 49 . 
NEUROPATHOLOGY OF INTRAVENTRICULAR 
HAEMORRHAGE 
Hydrocephalus is only one of the pathological processes that are a 
consequence of IVH. Two others are germinal matrix destruction and 
periventricular haemorrhagic infarction 73 . Both are important as they have a 
bearing on prognosis after IVH. 
Germinal matrix destruction 
Germinal matrix destruction results in loss of glial precursor cells which will 
prevent normal brain architecture and function. Haemorrhage in this area 
results ultimately in a cystic cavity the walls of which contain haemosiderin 
laden macrophages and reactive astrocytes. 
Periventricular haemorrhagic infarction 
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Approximately 15% of infants with IVH develop an area of haemorrhagic 
infarction in the periventricular white matter, just dorsal and lateral to the 
external angle of the ventricle. The lesion is asymmetrical and tends to occur 
on the side with the largest amount of ventricular blood. Half of these lesions 
are large and involve the white matter from frontal to occipital regions, the rest 
are more focal. Eighty percent are associated with large IVH and are often 
mistaken for IVH extension. The most likely cause of these lesions is venous 
haemorrhagic infarction caused by obstruction of the venous confluence in 
this area 73 . 
Other neuropathological states are common accompaniments of IVH but are 
not directly caused by IVH. The two most common are periventricular 
leukomalacia and pontine neuronal necrosis. 
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Periventricu/ar Jeukomalacia 
Periventricular leukomalacia is an ischaemic injury of white matter in the 
premature infant. It is generally symmetrical and non-haemorrhagic and in this 
way is distinguishable from periventricular haemorrhagic infarction. It is also 
more likely to occur in the periventricular arterial border zone near the trigone 
area as opposed to the venous confluence area more anteriorly. 
Pontine neuronal necrosis 
Hypoxic-ischaemic neuronal injury may accompany IVH in premature infants 
and a common pool of affected neurones is in the pons. Mortality from this 
lesion is high due to respiratory failure. 
NEUROPATHOLOGY OF POST-HAEMORRHAGIC 
HYDROCEPHALUS 
There is a large body of experimental evidence showing that ventricular 
dilation especially acute dilation, produces an array of anatomical effects on 
the cerebral parenchyma. Most of these studies have been performed in 
animal models using rabbits, monkeys, puppies or mice. It is difficult therefore 
to extrapolate these findings to premature infants where the brain is not yet 
myelinated, cells are still migrating and compliance of the cranium is very 
high. Nonetheless a number of predictable changes occur in these models 
which are likely to take place in neonates with PHH. Guzzetta et al have noted 
five main lesions: changes in the ependymal cells, periventricular white matter 
oedema, reactive gliosis, axonal changes and collapse of periventricular 
capillaries 19. 
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Progressive slow ventricular enlargement results in ependymal stretching, 
loss of cilia and microvilli as well as increased mitotic activity 15. In acute 
ventricular expansion ependymal continuity may be lost and an expansion of 
the neuropil extracellular space is usually found. Periventricular oedema does 
not extend far and is sharply demarcated 19. Hypertrophy and hyperplasia of 
periventricular astrocytes are usually found in hydrocephalus resulting in 
stiffening of the subependymal layer. Axonal changes amount to swelling, 
disruption and demyelination. Periventricular capillaries either collapse or are 
stretched by ventricular dilation and this change appears to be reversible with 
early shunting 14• 79 . 
Weller has demonstrated in a model using puppies that these pathological 
changes occur at certain times after the development of hydrocephalus. 
Hydrocephalus was initiated by infusion of silicone oil into the cisterna magna 
at birth. In the 20 and 40 day old puppies, where CSF pressure was raised, 
there was disruption of the ependyma, severe periventricular oedema and 
evidence of nerve fibre degeneration. No damage was seen in the cortex. 
With time CSF pressure returned to normal and periventricular oedema 
resolved. In 80 day old puppies a modified ependymal lining had reformed, 
oedema had resolved and a marked subependymal astrocytosis had 
occurred. Ectopic myelination of astrocytes was also noted. This is important 
as some studies use myelin content as a measure of white matter 
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preservation, which is misleading 75 . Weller goes further and tries to correlate 
these findings with biopsies taken from 5 hydrocephalic infants at different 
times after the evolution of hydrocephalus. Post-shunting outcome is then 
used as a measure of hydrocephalus induced brain injury. This is misleading, 
as the aetiology of hydrocephalus in each case appears to be different. One 
can not therefore infer correlation between the histological changes and 
clinical outcome in these cases. 
Synaptic vesicle protein (SVP) is a protein associated with synaptogenesis 
shortly after birth 70 and reduced amounts of SVP have been shown in rats 
with congenital hydrocephalus. Hydrocephalus in these animals is also 
associated with impaired dendritic and neuronal spine development. These 
changes were temporaly related to the development of raised intracranial 
pressure in these animals. Partial reversal of this pathology was achieved by 
early treatment of the hydrocephalus demonstrating a direct causal 
relationship between hydrocephalus and impaired synaptogenesis 70. It should 
be noted however that this is a model of congenital hydrocephalus and that 
SVP only increases for 3 weeks after birth. This age related increase may not 
occur in premature infants with IVH/PHH until a later time. 
Cranial compliance is so high in premature infants that the development of 
raised intra-cranial pressure (ICP) is not as prominent as in other age groups. 
Lin et al recorded ICP in 26 patients with PHH. Average recorded pressures 
varied from 4 to 40 mm Hg at rest with a mean of 17.8 mm Hg. Normal 
neonatal ICP is less than 5.6 mm Hg. In these patients no relationship was 
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demonstrated between ICP and outcome in terms of physical disability, 
sensorineural deafness, speech problems or visual handicap. It did appear 
however that raised ICP is associated with seizures. Six out of seven patients 
who had seizures also had significantly raised ICP 35 . 
GRADING OF INTRAVENTRICULAR HAEMORRHAGE AND 
POST-HAEMORRHAGIC HYDROCEPHALUS 
Grading of the severity of IVH is essential in determining the possible 
complications and prognosis after germinal matrix haemorrhage. The first 
classification of the severity of IVH was described by Papile et al. In 1978 
using CT scan 46 . The appearance of various degrees of intracerebral 
haemorrhage were correlated with the development of hydrocephalus 
(Table1). 
TABLE 1 
Severity of IVH according to Papile et al. 46 
GRADEi 
Subependymal haemorrhage 
GRADE II 
lntraventricular haemorrhage without ventricular dilation 
GRADE Ill 
lntraventricular haemorrhage with ventricular dilation 
GRADE IV 
lntraventricular haemorrhage with parenchymal extension 
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Use of this grading system is widespread and it is used in most published 
studies, however it does have some notable deficiencies. All haemorrhages 
must involve the parenchyma to some degree as the germinal matrix is 
located outside of the ventricle but in the hemisphere. There is also a wide 
spectrum of pathology in grade IV disease. Some patients may have only a 
small parenchymal clot whereas others may have more hemispheral blood 
than parenchyma. This may account for discrepancies in some studies where 
small parenchymal bleeds may be classified as grade Ill in some but grade IV 
in others. Other forms of parenchymal injury such as haemorrhagic infarction 
and periventricular leukomalacia are not included in this grading system, 
although haemorrhagic infarction may be inadvertently included as it appears 
to be an extension of matrix haemorrhage. Volpe has made an attempt to 
overcome this deficiency by including periventricular intra-parenchymal 
echodensity (IPE) as seen on ultrasound 74 . IPE is used as an approximation 
of the amount of parenchymal injury (Table 2). 
TABLE 2 
Grading of severity of IVH by ultrasound according to Volpe 74 
GRADEi 
Germinal matrix haemorrhage with no or minimal intraventricular 
haemorrhage ( < 10% of ventricular area on parasagittal view) 
GRADE II 
lntraventricular haemorrhage (10 -50% of ventricular area on 
parasigittal view) 
GRADE Ill 
lntraventricular haemorrhage (>50% of ventricular area on parasagittal 
view; usually distends lateral ventricle) 
Separate notation 
Periventricular echodensity (indicate location and extent) 
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Most grading systems have been described using a particular imaging 
modality ie. CT or ultrasound 46· 63· 74 . However the most often used imaging 
technique used in the neonatal Intensive care unit is real time cranial 
ultrasound and most studies grade IVH based on this. Performing a CT scan 
has been recommended if accurate determination of the amount of 
parenchymal injury is important such as in the decision to withdraw treatment. 
CT scan can more accurately determine parenchymal injury than ultrasound 
33
. More accurate assessment of parenchymal damage, after the first 
postnatal week, from ischaemia has been described using xenon-133 and 
positron emission tomography. The clinical usefulness of these investigations 
has yet to be determined 41 . 
The regression, stabilisation or progression of ventricular enlargement after 
IVH is well described 16• 25• 32 · 42· 49 . Serial ultrasound or CT scan investigations 
must be performed in order to assess changes in ventricular size and in 
severe grades of IVH (Ill & IV) this is usually done weekly. Holt has described 
objective measurements of ventricular size in order to categorise the degree 
of ventricular enlargement. Changes in size can then be accurately assessed 
from week to week and the need for treatment determined 25 (Table 3) 
TABLE 3 . . . 25 Grading of ventricular dilatation by ultrasound m PHH 
CORONAL VIEW SAGITTAL VIEW AXIAL VIEW GRADE VENTRICULAR CORTICAL BV.BP RA TIO DIAMETER MANTLE 
MILD <0.4 10-15 mm >6 mm 
MODERATE 0.4-0.6 15-20 mm -
SEVERE >0.6 >20 mm <5mm 
BV.BP RA TIO 
The biventricular-biparietal ratio is a ratio between the ventricular width and 
the width between the inner table of the skull. It is measured in the coronal 
plane at the level of the foramen of Monro. 
VENTRICULAR DIAMETER 
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The ventricular diameter is measured on the best true sagittal scan of the 
lateral ventricle. At a point corresponding to the 2 o'clock position on the 
posterior edge of the thalamus, a measurement is made at a 45° angle to the 
edge of the white matter. 
CORTICAL MANTLE 
This is the thickness of the brain parenchyma between ventricle and inner 
table of the skull at its thickest point. 
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MECHANISMS OF BRAIN INJURY IN IVH / PHH: SUMMARY 
Form the preceding discussion it can be seen that there a many insults to the 
premature brain associated with IVH and later PHH. These insults can be 
divided into four phases according to the time at which they occur 35 (Table 4). 
Included in this classification are injuries occurring as a result of the 
complications of hydrocephalus management. It is important when 
considering the optimal management of these patients to know which of all 
the insults causes the most brain injury. This is because one injury may be 
treated at the expense of increasing injury through some other mechanism. 
An example is early lumbar puncture therapy to lower raised intracranial 
pressure which increases the incidence of meningitis 20· 67 . From available 
studies it appears that the primary injury of IVH is the most important factor in 
determining prognosis (see outcome studies Chapter 4). This is only true 
however as long as central nervous system (CNS) infection does not occur as 
a complication of therapy in the treatment of PHH. Cerebrospinal fluid 
infection is one of the worst insults that the developing brain can 
sustain 35, 40, 61, 67_ 
25 
TABLE 4 
The four phases of brain injury following neonatal IVH / PHH 35 
PHASE 1 
The primary insult of IVH 
1. Prenatal hypoxic-ischaemic encephalopathy 
2. IVH acting as a space occupying lesion 
3. Dissecting injury from haemorrhage 
PHASE 2 
Secondary injury from postnatal hypoxic-ischaemia 
1. Shock/ coagulopathy 
2. Hypotension 
3. Disordered cerebral autoregulation 
4. Raised ICP 
5. Reduced cerebral perfusion pressure 
6. Seizure induced increase in cerebral metabolism 
7. Apnoea, pneumothorax: Hypoxaemia 
PHASE 3 
Tertiary injury from raised ICP and ventriculomegaly 
1. Impaired cerebral blood flow 
2. Brain shifts 
PHASE 4 
Quaternary injury from raised /CP 
1. Complicating VP shunt block 
2. Shunt over-drainage 
3. Isolated fourth ventricle 
4. CSF infection 
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CHAPTER 3: MANAGEMENT OF 
INTRAVENTRICULAR HAEMORHHAGE AND 
POST-HAEMORRHAGIC HYDROCEPHALUS 
PREVENTION OF INTRAVENTRICULAR HAEMORRHAGE 
Strategies for preventing IVH are essential as survival rates for low birth 
weight infants increase. Interventions can be prenatal or postnatal and target 
the various mechanisms of pathogenesis discussed earlier. 
PRENATAL INTERVENTION 
Prevention of preterm birth 
The incidence of IVH increases as gestational age and birth weight decrease 
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. This illustrates the importance of preventing premature birth or delaying 
delivery as long as possible. 
Transportation in utero 
If premature labour and delivery can not be prevented then the pregnant 
mother should be transported to a regional centre with neonatal ICU facilities. 
The incidence of IVH is high in premature infants transported after delivery 74 . 
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Prenatal pharmacological interventions 
Phenobarbital may reduce the incidence and severity of IVH if given 
antenatally although evidence is not conclusive. Vitamin K may also be of 
benefit given that premature infants have only 60% of adult levels of vitamin K 
dependent coagulation factors 74 . Antenatal steroids which enhance fetal lung 
maturity have reduced the incidence of IVH. 
Atraumatic labour and delivery 
Precipitous labour and delivery can lead to deformation of the soft, compliant 
neonatal skull with resulting injury and loss of cerebrovascular autoregulation. 
Despite this the role of caesarean section remains unclear. 
POSTNATAL INTERVENTION 
Resuscitation of the newborn 
Over-rapid volume expansion during resuscitation can lead to increased 
cerebral blood flow, which as discussed previously is a factor in the 
pathogenesis of IVH. It is also prudent to consider early, atraumatic ventilation 
as cerebral autoregulation is often disturbed. Hypercarbia is a common finding 
and can lead once again to increased cerebral blood flow. Hyperventilation 
and hypocarbia has been shown to restore cerebral autoregulation but also 
causes cerebral vasoconstriction and limit oxygen delivery. For this reason it 
is probably best to recommend normo-ventilation only. 
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Correction of fluctuating cerebral blood flow and arterial and venous pressure 
Cerebral blood flow fluctuation is seen primarily in ventilated infants with 
respiratory distress syndrome. Because of the almost invariable relationship 
between this and IVH, infants may be given muscle paralysis to restore a 
stable pattern of cerebral blood flow and venous pressure. Care should also 
be taken to prevent sharp elevations in arterial blood pressure. Excessive 
handling and tracheal suctioning should be avoided and intra venous 
infusions should be administered with caution. 
Correction of coagulopathies 
Although some infants with IVH will have a coagulopathy that needs 
intervention not all patients will require action to correct or prevent such 
abnormalities. 
Pharmacological interventions 
In an effort to reduce the incidence and severity of IVH, phenobarbitol, vitamin 
E and ethamsylate have all been administered postnatally with inconclusive 
results. The benefit of postnatal indomethacin was also doubtful until recently. 
Ment et al have shown in a large prospective, randomised, placebo-controlled 
trial that low dose intravenous indomethacin lowers the incidence and severity 
of IVH. The mechanism of action of indomethacin is unclear but may involve 
scavenging prostoglandin-mediated free radicals or inhibiting active calcium 
transport in vascular smooth muscle. Experimentally indomethacin has been 
shown to decrease cerebral blood flow, decrease post asphyxia! reactive 
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cerebral hyperaemia and accelerate germinal matrix microvasculature 
maturation. Importantly it also did not result in extension of pre-existing IVH 43 . 
PREVENTION OF POST-HAEMORRHAGIC HYDROCEPHALUS 
It is assumed that hydrocephalus occurring after IVH is as a result of CSF 
pathway obstruction initially by blood clots and later by subsequent collagen 
formation. If this is true then early fibrinolysis of the ventricular clot in an effort 
to clear CSF pathways may prevent the development of hydrocephalus. 
In 1992, Whitelaw et al. demonstrated that low dose intraventricular 
administration of streptokinase enhanced endoventricular fibrinolysis and 
prevented permanent hydrocephalus in 8 of 9 infants with post haemorrhagic 
ventricular dilation 77 . 
A prospective, randomised case control study was performed by Luciano et 
al. following this positive experience. Using the same dose of streptokinase as 
Whitelaw et al. 10 patients were treated, 5 in the fibrinolysis group and 5 in 
the control group. Three patients in each group eventually required ventriculo-
peritoneal shunt placement. The fibrinolysis group also had the complications 
of ventriculitis in one patient and rebleeding from the germinal matrix in 
another. The conclusion was that streptokinase treatment should not be 
administered soon after IVH, unless progressive ventriculomegaly occurs 36 . 
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It is difficult to draw conclusions from these small studies however the 
complications of intraventricular streptokinase are cause for concern. 
Administration of fibrinolytics in the late phase of IVH/PHH, as suggested by 
Luciano, is probably also inappropriate. The arachnoiditis caused by IVH may 
start soon after the haemorrhage and early blood clearance would be 
preferable. Suggested causes of failure of therapy are firstly that enhanced 
fibrinolysis seen in ventricular fluid was not obtained at the arachnoid villi and 
secondly that mechanisms other than fibrinolysis are responsible for the 
clearance of CSF blood clots 36. 
THERAPEUTIC OPTIONS FOR THE TREATMENT OF POST-
HAEMORRHAGIC HYDROCEPHALUS 
There are a number of issues that need to be considered when deciding on a 
therapeutic course for an infant with PHH. 
Natural history of PHH 
Several studies have shown that only a minority of infants with IVH will 
develop hydrocephalus and most of these patients will have had grade Ill or 
IV haemorrhage 32· 42 ' 63. Of the infants with dilated ventricles only a minority 
will progress to PHH requiring a shunt. Results of 3 studies showing the 
natural history of the disease where no or minimal intervention occurred are 
shown in table 5. 
TABLE 5 
Incidence of PHH in infants with IVH from 3 studies where there was 
minimal intervention. 
Levene and Shankaran Ment 
Starke 32 et al. 63 et al. 42 
202 242 438 
Total patients enrolled Neonatal Neonatal VLBW 
admissions admissions Infants 
Patients with IVH 68 62 133 
Surviving patients who 
developed ventricular 15 26 Unknown 
dilatiOfl 
Patients who had 
progressive hydrocephalus 
with raised ICP and 3 11 5 
increasing head size 
requiring therapy 
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Given the tendency for some patients to have spontaneous resolution of 
hydrocephalus up to one month after IVH it is prudent not to rush into a 
definitive shunting procedure that will leave the patient shunt dependent. 
Many authors recommend initial "conservative" therapy (combinations of 
medical therapy and lumbar puncture) in order to identify the patients who will 
have persisting raised intracranial pressure 12· 16· 32· 42· 63· 64· 68. 
Protection of the cerebral mantle 
Progressive ventricular enlargement due to abnormal CSF absorption can 
cause cerebral injury through either raised intracranial pressure or mechanical 
32 
disruption of brain tissue from ventricle dilatation. However not all infants with 
enlarging heads will have raised ICP 29• 35 . This is because of the high 
intracranial compliance that these infants have. Furthermore there is little 
evidence to support the contention that raised ICP causes significant 
neurological injury in this group of patients. In the evaluation of ICP after IVH 
in 26 patients Lin et al. could show no correlation between raised pressure 
and poor neurological outcome 35 . On the other hand there is no debate that 
hydrocephalus in older children and adults requires prompt treatment in order 
to limit the effects of raised ICP. Studies that recommend early surgical 
treatment of PHH base their recommendation on experience with these older 
patients. 
Regarding mechanical injury of the brain, it appears that this takes place in an 
ordered sequence. White matter injury occurs first with remarkable sparing of 
the cerebral cortex 58 . Reconstitution of the mantle after successful shunting is 
a well-recognised phenomenon in infants with hydrocephalus 37. It is 
presumed that this increase in mantle thickness is from shortening of 
previously stretched white matter fibres and a reduction of the circumference 
of the cortex. It would seem logical that there is a limit in terms of time and 
thickness beyond which this recovery will not take place, but as yet these 
values are unknown. Consequently, any decision regarding timing of a 
surgical intervention remains subjective. 
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Complications of surgical therapy in premature children 
In the early stages of IVH patients are often unstable. They are usually nursed 
in an ICU with invasive monitoring and many require ventilation. Until the 
development of real time high-resolution ultrasound even investigation of IVH 
was difficult as it required moving labile patients to a CT scanner. 
Any surgical intervention during this early period increases the risk of 
sustaining iatrogenic complications. It has been noted that excessive 
stimulation of infants can lead to progression of IVH (see pathogenesis of 
IVH). Moving infants into the operating room environment also exposes 
patients to the risks of hypothermia and haemorrhage. Premature patients are 
also at high risk of developing infections for a variety of reasons such as poor 
immune system function, skin fragility and colonisation with pathogenic flora. 
Surgical procedures that result in the implantation of foreign material such as 
shunts and reservoirs therefore dramatically increase the risk of CNS infection 
13,60,61 
MEDICAL THERAPY FOR PHH (PHARMACOLOGICAL 
INTERVENTION & LUMBAR PUNCTURE) 
Pharmacological intervention in order to reduce the volume of CSF produced 
has been proposed as a therapeutic option for PHH 64· 68 . Acetazolamide is a 
carbonic anhydrase inhibitor that partially blocks the formation of water by the 
choroid plexus thereby acting directly on CSF production. Furosemide is the 
other commonly used agent and has a diuretic effect that ultimately reduces 
CSF formation secondary to dehydration. 
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Cerebra-spinal fluid (CSF) turnover per day is approximately 3 times which 
means that far more CSF is produced per day than is present within the 
central nervous system at any one time. For this reason even a significant 
reduction in CSF production (up to one third) does not change intracranial 
pressure by more than 1.5 cm of water when there is a large imbalance 
between production and absorption as in PHH 39 . Pharmacological 
intervention is therefore only likely to be of help as an adjunct to some other 
form of therapy or when hydrocephalus is only slowly progressive. These 
agents also have adverse effects causing disturbances of electrolytes, acid 
base balance and haemodynamic instability. 
Lumbar puncture (LP) has been widely used as a method of temporarily 
treating PHH before a definitive shunting procedure 2· 11 ·16·47· 67• 78 . The 
procedure is usually performed daily and either a specific amount of CSF is 
drained 39• 78 or drainage is continued until a specific pressure is attained 16. 
In theory it would seem to provide a comparatively safe way of reducing ICP 
and limiting brain injury to that caused by the primary insult. It can be 
performed in the neonatal nursery on a regular basis until the infant is well 
enough to tolerate a surgical operation. However despite its appeal, studies 
have not shown any improvement in neurological outcome or a decrease in 
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the number of patients eventually requiring a shunt. The results of randomised 
trials evaluating LP therapy are summarised in table 6. 
TABLE 6 
Outcome of patients randomised to LP or conservative therapy for 
treatment of PHH 
Whitelaw 78 Dykes 16 Anwar 2 
Total patients enroUed 157 38 47 
LP / Conservative 79 I 78 22 I 16 not randomised 
Patients requiring shunt 41 / 42 No numbers Equal shunts 10 / 9 LP / Conservative Both groups 
Adverse outcome & Death 58 / 60 12 / 11 Not assessed LP / Conservative 
Good outcome 9/9 6/3 Not assessed LP / Conservative 
CNS infections 7/4 unknown unknown LP / Conservative 
No statistically significant difference in outcome was shown in any of these 
trials. In addition it appears that in the largest study, by the Ventriculomegaly 
trial group, there was an increased incidence of infection in the LP group. 
Although this difference was not statistically significant, other authors have 
also raised the concern that lumbar puncture could provide a portal of entry 
for infection in these patients 78. 
There are also other potential drawbacks to performing serial LP's. Lumbar 
drainage of CSF is not possible in all patients, as some will have obstructive 
hydrocephalus. In the ventriculomegaly trial group up to 25% of patients also 
required ventricular taps as insufficient CSF was obtained by LP 78. Premature 
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infants also have to suffer the stress of frequent painful punctures which may 
last from 15 to 60 minutes. Finally if lumbar punctures are effective relatively 
large amounts of CSF may be drained over a short period of time. This can 
result in disturbances of cerebral circulation 39 , apnoea 78 , loss of protein and 
electrolyte disturbances 20. 
VENTRICULAR TAP, VENTRICULAR DRAINAGE & 
VENTRICULAR RESERVOIR 
VENTRICULAR TAP 
The anterior fontanelle is open in premature infants so transcutaneous 
aspiration of ventricular CSF by needle puncture is a simple procedure. A 
short spinal needle is introduced into the ventricle at least 1 cm off the mid line 
at the level of the coronal suture. This technique has been described as a 
temporising treatment for PHH when LP fails 78 . It does have potential 
complications however. Firstly repeated taps carry the risk of parenchymal 
tract injury 24 and haemorrhage and secondly there is a chance of introducing 
infection. For these reasons ventricular tap has not been a popular method of 
treatment. 
VENTRICULAR DRAIN 
External ventricular drainage has been described by a number of authors as 
an effective therapy for PHH 16· 20· 23· 38· 76 . It offers the advantages of 
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continuous CSF drainage, pressure monitoring and when ideally performed 
requires only a single brain parenchymal tract. Weninger has also reported, in 
a series of 27 infants, being able to insert the ventricular catheter in the 
incubator using local anaesthetic. Because the patient does not have to be 
moved the drain can be inserted early when the infant may still be unstable. In 
this series drains were inserted at a mean age of 14 days (range 3-28 days) 
and all patients showed a decrease in ventricle size within 2-3 days. Three 
patients died, 7 had resolution of their hydrocephalus and 17 went on to VP 
shunt placement. No serious complications were associated with drain 
placement or maintenance although 12 revisions were required for drain 
blockage, accidental dislocation and CSF leak. It is notable that there were no 
cases of clinical ventriculitis in this group even although CSF culture was 
positive on 7 occasions. These cultures were presumed to be positive 
because of exogenous contamination 76 . This is in contrast to another series 
reported by Hahn where 9 out of 15 patients (60%) required treatment for 
infection while undergoing ventricular drainage 20 . There are no reports 
comparing this form of therapy to any other and numbers in all reported series 
are small so assessment of the effectiveness of the intervention is unclear. In 
Weninger's series all patients with grade IV IVH had a poor outcome and 
these patients were felt not to benefit from early hydrocephalus treatment. Of 
the patients with grade Ill IVH 41 % had a good outcome and it is suggested 
that these patients may have obtained benefit from early treatment 76 . 
Technical improvements in external ventricular drainage such as Broviac 
ventriculostomy have been reported in an effort to improve on the frequent 
complications of catheter dislodgement and infection 10. In this instance a 
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catheter with a dacron cuff is tunnelled subcutaneously before exiting into a 
bag. The cuff ensures that the catheter does not move and a fibrous response 
to the dacron limits retrograde bacterial colonisation of the catheter. 
VENTRICULAR RESERVOIR 
In order to overcome the complications of external ventricular drainage some 
authors have suggested inserting a ventricular catheter with a reservoir under 
the scalp 37· 39· 52 . As with lumbar puncture or ventricular tap, CSF is removed 
on a daily basis until either the hydrocephalus resolves or the patient is stable 
enough to undergo definitive shunting. McComb reported on the outcome of 
this procedure in 20 patients. Reservoirs were inserted on average by the 1 ih 
day of life (3-30 day range) in an operating room and improvement in cortical 
mantle thickness was observed in survivors 39 . It is unfortunate however that 
13 patients died in this series and although the causes were not thought to be 
procedure related most deaths occurred within 30 days of operation. This is 
considered to be an operative mortality in most reports. In another series of 
12 patients, catheter placement occurred at a later age (mean 23 days) 37_ 
Cortical mantle thickness was improved on follow-up CT scan in surviving 
patients. Only 1 patient avoided a VP shunt, 7 patients died and 2 developed 
catheter related infections. The numbers in these series are very small and 
the mortality was high in both so it is not possible to make any comment on 
the effectiveness of this therapy. 
VENTRICULAR SHUNT 
VENTRICULOSUBGALEAL SHUNT 
The insertion of a ventricular catheter that drains into an undermined 
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subgaleal space has the possible advantage of allowing continuous CSF 
diversion from the ventricle. Sklar et al described this operation as a 
temporising procedure in 62 infants with PHH before VP shunts were inserted 
66
. The operation was performed in an operating room under general 
anaesthesia. No information is given regarding the age at which this 
intervention was made but 80% of infants were reported to show a decrease 
in ventricle size. Seven patients died with one death directly related to scalp 
necrosis and infection at the site of the operation. The overall infection rate 
was 10% and a further 10% avoided a permanent shunt. More recently 
Rahman has reported a small series of patients undergoing the same 
treatment 56 . Fifteen patients had ventriculosubgaleal shunts inserted at an 
early age. All showed stabilisation of ventricular size but 80% went on to 
require insertion of a VP shunt. No infection was reported in this series. Again 
an opinion on whether outcome was improved by early intervention can not be 
made based on these reports. Some critical observations regarding this 
technique have been made 12 . First, the addition of tunneling and abdominal 
insertion of a distal catheter to the shunt does not substantially increase the 
time required for surgery or its morbidity. The omission of these steps only 
reduces the incidence of peritoneal complications such as respiratory 
compromise or retrograde spread of infection with necrotising enterocolitis. 
Second, use of the described "Omaya reservoir connectors" should be 
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avoided in this patient population because of the high incidence of ventricular 
catheter disconnection. This is a procedure that has not gained universal 
acceptance. 
VENTRICULOPERITONEAL SHUNTS 
Ventriculoperitoneal shunting is the definitive therapy for PHH although it is 
seldom the only intervention. Most patients are initially managed with one of 
the previously described treatments in an effort to exclude those who will have 
resolution of their hydrocephalus and allow for stabilisation prior to a surgical 
procedure 6, 18, 20, 26, 27, 33, 38, 50, 51, 52, 55, 60, 63_ However there are a few reported 
series where insertion of a VP shunt is described as the only therapy 4• 34• 48 . 
Ultimately shunts are inserted for two reasons. Firstly, a VP shunt provides a 
reasonably physiological way of maintaining normal intracranial pressure and 
in this way limits brain injury. Secondly, a shunt may be required for cosmesis. 
Even the infant with irreversible severe neurological injury may benefit from a 
shunt to decrease head size to a dimension that is easily nursed. This not 
only allows parents to bond with their child but also prevents complications 
such as pressure sores. 
There is no doubt that shunts are required for the long term treatment of PHH, 
however their use is fraught with complications in this group of patients 6• 13 27• 
33
• 
35
• 
38
• 
55
• 
59
• 
60
· 
61
. Table 7 shows the complications related to VP shunting in 5 
representative series. 
TABLE 7 
Complications of ventriculoperitoneal shunts in PHH 
Scarff James Lin Mccallum Le% 
et al 60 et al 27 et al 35 et al 
38 etal 
1983 1984 1992 1994 1997 
Total number of 20 53 27 50 47 
shunted patients 
Average age at the 4.5 31 .5 days 8 weeks 26 days 52 days 
time of shunting weeks 
Number of shunt 5 18 13 8 3 infections (25%) (27%) (48%) (17%) (6.3%) (%) 
Number of patients 10 14 24 47 39 
with shunt (50%) (26%) (89%) (94%) (83%) 
obstruction 
Total number of 16 23 -92 163 209 
revisions 
Operative mortality 0 1 0 3 0 
Follow-up period short Nursery 9mth-3 2-5 years 
Up to 16 
stay years years 
Adjunctive therapy LP LP EVD Reservoir Ventricular prior to shunting Tap 
LP - Lumbar puncture 
EVD - External ventricular drain 
These results demonstrate the high incidence of infective and obstructive 
complications in PHH and this is confirmed in studies that have stratified 
complications according to the aetiology of hydrocephalus 13· 61 . 
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Many reasons for the high incidence of complications have been proposed. 
Shunt infection is higher in infants under 6 months of age 13. Renier and co-
workers attributed this high incidence of infection to declining levels of 
maternal lgG during the first 6 months of life prior to the build up of specific 
antibodies. In addition compliment activity and cellular immunity are lower and 
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less efficient than in adults 57 . This theory remains controversial however as 
other authors maintain that immunoglobulins, compliment and cellular 
immunity have little effect once organisms have entered the ventricles 53 . 
Another reason could be the age-related skin changes and the presence of 
high- density colonies of coagulase negative staphylococcus in young infants 
53
. IVH also seems to constitute a specific risk factor for infection irrespective 
of patient age. Haemorrhage remnants in the ventricles probably diminish the 
effectiveness of local defence systems 61 . 
Controversy also exists regarding the reasons for the increased incidence of 
shunt obstruction. Many authors cite the high protein levels found in the CSF 
after IVH as the cause 24· 26 · 27· 51 · 60 . Mechanisms whereby the high protein 
has been postulated to affect shunt performance include, increased CSF 
viscosity, valve sticking due to protein, protein deposition in the lumen and a 
greater susceptibility to infection. Other groups, however have shown CSF 
protein levels to have no relationship to shunt malfunction 4· 8· 9 · 55 . In a study 
looking specifically at shunt complications and CSF protein levels in 95 
patients Brydon et al showed no statistical relationship between protein levels 
and either obstruction or infection 9. In another study by the same authors 
reduced bacterial adhesion to shunt catheters was demonstrated in the face 
of increased protein levels, illustrating that protein may in fact protect against 
infection 7. 
High red blood cell counts in the CSF have been shown to increase the 
incidence of shunt obstruction 8·55 . Several reports have also shown a higher 
43 
complication incidence in patients who were shunted at a young age 
presumably with more RSC and their products still present in the CSF 6·18· 26• 
55
. CSF protein content correlates well with the extent of IVH and this has 
perhaps been the confounding variable in studies looking at CSF protein 28. 
Blood clearance from the ventricles after IVH is variable but in most cases 
clears considerably in the first month 39. The timing of shunt placement 
remains controversial as a balance must be achieved between the incidence 
of complications with early surgery and the probability of neurological injury 
with delayed shunting. Other complications such as skin breakdown over the 
shunt and CSF accumulation around the burrhole have also been described 
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In order to overcome the complications of shunting in these patients some 
technological innovations in shunt design have been suggested. In 1979 Sada 
recommended using distal catheters with a 1 cm triple-slit to limit obstruction 
due to coagulum 4. James et al later suggested a low-pressure system with 
the distal catheter open below the level of the slit valve to further reduce the 
chance of obstruction 27 . More recently the Ammar shunt has been specifically 
designed for premature infants with PHH 1. The shunt is made of soft silicone, 
has a small configuration and the entire shunt acts as a low-pressure valve. 
No trial has yet been conducted to assess if any of these innovations are 
beneficial. 
CHAPTER 4: OUTCOME OF PATIENTS 
WITH INTRAVENTRICULAR 
HAEMORRHAGE AND POST-
HAEMORRHAGIC HYDROCEPHALUS 
IVH AND OUTCOME 
lntraventricular haemorrhage is the commonest cause of morbidity and 
mortality in very low birth weight infants (VLBW). In a review of 22 
publications documenting the outcome of VLBW infants it was shown that 
more and more infants are surviving the respiratory complications of 
prematurity 69 . As this occurs the neurological deficits in survivors are 
becoming more prominent. 
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The strongest predictor of outcome in patients who sustain IVH is the grade of 
haemorrhage 16· 28 · 45·22 . For this reason it is important to serially evaluate the 
extent of IVH in the germinal matrix as progression can occur over days. 
Correlation between outcome and grade of IVH from several representative 
reports are shown in table 8. 
TABLE 8 
Relationship between IVH Grade and outcome. 
Krishnamoorthy 1979 1 yr 28 
N = 15 
Normal 
Mild-Moderate 
Severe 
Dykes 1982 1yr 18 
N = 59 
Normal 
Abnormal 
o Died 
C: 
c=, Papile 1983 1yr 45 
O N = 198 
3 
ro Normal 
Mild 
Severe 
Multi Handicap 
Hanigan 1991 18 mth 22 
N=97 
Normal 
Suspect 
Abnormal 
IVH Grade 
ocln=3 II n=9 111 n=O 1Vn=3 
1 6 
2------- ________ 3 ________ ------------------ - 1 
---------------- ----- ---------- -- --- --------- :2 
Mild Moderate *Severe 
n=10 n=:26 n=:26 
5 8 4 
-------- -- ------ ________ 9 ________ ---------- 6 
_______ 5 _______ ------- 7 15 
ocl 
16 
14 
3 
:2 
ocl 
15 
15 
7 
II 
9 
7 
:2 
0 
II 
:2 
3 
5 
111 
:2 
7 
5 
4 
Ill 
1 
:2 
5 
IV 
:2 
:2 
13 
10 
IV 
0 
1 
7 
oclVH grading according to Papile 
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*In the study by Dykes et al. the severe grade of IVH included Papile grades 
Ill & IV. 
46 
PHH AND OUTCOME 
Regarding the outcome of infants with PHH it is far more difficult to ascertain 
which factors other than grade of initial IVH have an effect. Most patients who 
develop PHH have either grade Ill or IV IVH and a high percentage are 
therefore severely disabled. Studies reviewing this topic show a worse 
neurological outcome related to IVH grade, increased number of shunt 
revisions, CNS infection and seizures 6, 11, 16, 20, 22, 24, 26, 28, 33, 35, 38, 39, 54, 62, 63, 76_ 
These factors may of course also be inter-related. The incidence of shunt 
infection increases with the number of times the shunt needs to be revised 
and seizures may be related to extensive IVH resulting in cortical injury. In a 
logistic regression analysis Levy et al demonstrated that grade of 
haemorrhage was by far the most important variable in determining cognitive 
outcome, motor function and the presence of seizure activity (P < 0.0001 ). In 
the same study a logistic model of survival determined that grade of 
haemorrhage and multiple shunt revisions (more than 5) were the most 
important determinants of survival (P < 0.0001 )(Levy). 
Outcome results from studies dealing only with patients with PHH are shown 
in table 9. 
TABLE 9 
Developm~ntal outcome in patients' treated for PHH in previously 
published reports. 
STUDY Patients Normal% Delayed% 
Severely 
delayed% 
Cooke 54 44 31 17 1987 
Hanigan et al. 16 6 19 75 1991 
Mccallum 47 38 11 40 
1994 
Resch et al. 63 15 67.5 17.5 1996 
Levy etal. 72 24 11 22 1997 
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Dead% 
7 
11 
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Variations in the results of these studies probably reflect differing distributions 
of poor grade patients rather than differences in management. In the study by 
Levey et al. there were 18 patients with grade IV haemorrhage. None of these 
patients had a normal outcome and most were severely disabled having both 
spastic quadriparesis and a developmental quotient more than 2 standard 
deviations below the mean 33. 
The effects of hydrocephalus on outcome 
Does hydrocephalus alter outcome in patients with IVH? This is a difficult 
question to answer as the complications of VP shunt insertion may obscure 
the pathological effects of ventricular enlargement and raised ICP. Opinion in 
the literature remains divided on this issue. Some authors have indicated that 
hydrocephalus is a predictor of poor outcome 31 • 62• 71 . In a study by Laurent et 
al. looking at outcome in 43 patients IVH grade was not as good a predictor of 
handicap as the presence or absence of hydrocephalus 31 . Papile et al also 
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showed that although patients of similar grade IVH with and without 
hydrocephalus had the same incidence of handicap, the hydrocephalus group 
tended to have more multi-handicapped patients 45 . Failure of ventricular 
decompression after shunt insertion has also been suggested as an indicator 
of poor outcome 62 . The reasoning that this is because hydrocephalus related 
injury has become irreversible is flawed however, as this may only represent 
progressive atrophy after parenchymal injury from other causes. 
There is also a body of evidence indicating that hydrocephalus per se is not a 
factor in neurological outcome 11 · 22· 28· 35· 62 . In a study looking at the effects of 
ICP in PHH in 26 infants no correlation was shown between raised ICP and 
outcome 35 . Cooke also demonstrated a strong correlation between the 
presence of porencephaly on ultrasound and outcome in 54 infants 11 . These 
abnormalities were noted before the onset of hydrocephalus. As has been 
mentioned previously many studies show a clear relationship between shunt 
complications in the treatment of hydrocephalus and increased morbidity and 
mortality 16, 24, 33, 35, 54, 62, 11. 
The cost of treating PHH 
There have been two published reports on the cost of treating infants with 
PHH. Both studies only looked at the treatment of infants with grade IV IVH. In 
1994 Mccallum looked at the cost of initial hospitalisation in 50 infants with 
PHH. The average cost was US$ 194 776 per patient. The additional costs 
thereafter of complicated and uncomplicated shunt revisions were US$ 4 
692/patienUyear (Infection incidence= 4.9%/patienUyear and shunt 
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obstruction = 0.49 revisions/patient/year). There were only 15 patients in this 
study who were considered to be self sufficient and if the figures are adjusted 
to show cost per self sufficient child then the average is US$ 808 125 for the 
first 20 years of life 38 . This only includes the costs of hospitalisation and the 
fees of the neurosurgeon and neonatologist. It does not take into account the 
costs of rehabilitation or visits to other specialists. 
In a more recent publication reviewing a series of 52 patients treated between 
1977 and 1987 Pikus et al. estimated the cost of first hospitalisation at US$ 
150 000 per patient. No patient in this study had a normal outcome 52 . The 
conclusion in both of these papers was that the cost-benefit analysis of the 
treatment of PHH after high grade IVH was discouraging. 
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CHAPTER 5: REVIEW OF SHUNT 
COMPLICATIONS AFTER THE TREATMENT 
OF POST-HAEMORRHAGIC 
HYDROCEPHALUS OVER AN 8-YEAR 
PERIOD. 
INTRODUCTION 
The incidence of intraventricular haemorrhage in very low birth weight infants 
has been reported to be decreasing in a number of neonatal centres over the 
past decade. Recent reports indicate that the incidence of IVH is around 25% 
to 50% in this group of patients 18· 19· 22· 33• 52· 73 . Nonetheless with advances in 
neonatal care more premature infants with IVH are surviving. Approximately 
13-60% of the patients with IVH will develop progressive haemorrhagic 
hydrocephalus (PHH) and 22% to 70% of these will require CSF diversion 3· 16· 
18
· 
32
• 
39
· 
49
· 
54
· 
63
. The most commonly performed procedure for the treatment of 
PHH is insertion of a ventricoloperitoneal shunt (VP shunt) as this offers the 
most permanent solution. Unfortunately VP shunts in low birth weight infants 
with IVH have a universally high complication incidence 6· 13· 27· 35· 38, 55, 59, 60, 51 _ 
This tends to add to an already high morbidity, mortality and cost. It was the 
aim of this study to review the timing of surgery for VP shunt insertion to 
ascertain if this in any way influenced the complication incidence. 
PATIENTS AND METHODS 
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Forty one patients were referred to the paediatric neurosurgery department at 
Red Cross War Memorial Children's Hospital during the 8 year period from 
January 1989 to December 1996. A retrospective review of the patients' 
clinical notes was undertaken looking at birth weight, IVH grade, patient age 
at the time of surgery and complications occurring after surgery. 
Complications included VP shunt obstruction, shunt infection and death. 
Only 36 of these patients are included in the study as insufficient data was 
available for 5 patients. All patients were referred from 3 surrounding neonatal 
units (Mowbray Maternity Hospital, Somerset Hospital, Groote Schuur 
Hospital) once progressive hydrocephalus became apparent on serial trans-
fontanelle ultrasound, or on clinical examination. In all cases the diagnosis of 
IVH and subsequent Papile grading 46 was made using transfontanelle 
ultrasonography. Most patients also had a cranial computed tomography (CT) 
scan prior to insertion of a VP shunt. Before surgery was performed no 
attempt was made to treat the hydrocephalus by lumbar puncture or 
ventricular tap. There was also no administration of thrombolytic agents to try 
and clear the IVH. 
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VP shunts were inserted in an operating room with perioperative antibiotic 
cover for 24 hours. Two types of VP shunt were used; Cadman and 
Chadbara. Both were distal slit valve medium pressure shunts with distal and 
proximal catheters connected by a right angle connector. A right occipital 
burrhole was used to place the ventricular catheter into the frontal horn of the 
right ventricle where possible and a subcostal inscision was used for 
peritoneal access. One patient had a ventricular reservoir inserted on day 31 
which was tapped intermittently prior to VP shunt insertion 60 days later, and 
another had an external ventricular drain placed at 32 days of age with shunt 
insertion on day 52. 
In most patients a routine post-operative CT scan was performed prior to 
discharge to assess the ventricular position of the VP shunt and size of the 
patients ventricles. During the study all patients were under the care of one 
consultant Neurosurgeon and one of 5 rotating registrars. The shortest follow-
up interval was 5 months and the longest 5 years with an average interval of 
2.2 years. 
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RESULTS 
All of the patients tolerated the surgical procedure well with no intra-operative 
or immediate post-operative complications. Birth weight was below 2000 
grams in all but 1 patient with a range from 740 to 2100 grams (mean 1312 
grams). 
The IVH grade was I in 1 patient Ill in 23 patients and IV in 12 patients. 
Surgery for VP shunt insertion was undertaken between day 13 and 124 after 
birth with a mean of 42 days. 
Complications were divided into VP shunt obstruction requiring revision, shunt 
infection and death. 
Shunt Obstruction: 
Nine out of the 36 patients (25%) required revision of their shunt after 
obstruction during the study period with a total of 21 revision procedures 
performed. The range in the number of revisions performed was 1 to 6 per 
patient. This excludes patients who had shunt failure related to infection. 
Seven of the patients (19%) had revision of their shunt during the initial 
admission prior to discharge (early revision). This is an important result as it 
excludes the patients who had later revisions documented because of a long 
follow-up period. Of the patients who had early revisions 2 went on to require 
later revisions after their discharge from hospital. 
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Infection: 
Shunt infection occurred in 4 patients (11 %), all during the initial hospital 
admission. Two patients acquired Klebsiella shunt infections with the insertion 
of the initial shunt and were treated with external ventricular drains and 
antibiotics. One patient had the external drain converted to a shunt after the 
cerebrospinal fluid cell count dropped below 5 white cells and cultures grew 
no organisms. The other patient underwent a prolonged course of antibiotic 
administration and ventricular drainage. There was no improvement in the 
cerebrospinal fluid cell count during this time and eventually the ventricular 
drain was removed and the patient was discharged home for a period of 
months. A follow-up CT scan on this patient demonstrated locculated, isolated 
ventricles of differing density. Further CSF diversion was not attempted and 
the hydrocephalus was allowed to progress. One patient developed infection 
with Staphylococcus epidermidis after conversion of a ventricular reservoir to 
a VP shunt. Five further revisions were performed before this patient was 
discharged in a severely disabled state. The last patient had infection with a 
Staphylococcus aureus organism and died from the infection after 3 shunt 
revisions. 
Mortality: 
Four patients died. One patient had a VP shunt related death and died from a 
shunt infection at age 8 months. In the other 3 patients mortality was related 
to pneumonia. Two patients died at age 1 year and 1 at the age of 2 years. 
Neurodevelopmental outcome 
Sixteen patients had a record of neurodevelopmental outcome recorded in 
their hospital folder. Results are shown in table 10. 
TABLE10 
Neurodevelopmental outcome 
Outcome 
Normal 
Mild handicap 
Moderate handicap 
Severe handicap 
Shunted before Shunted after 
5 weeks 5 weeks 
0 1 
2 
2 
4 
2 
0 
5 
CT scan appearance after shunting 
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Scans done at variable intervals after insertion of a shunt were reviewed in 18 
patients. Thirteen patients had recovery of cerebral mantle thickness and 5 
showed atrophy. Of the patients shunted after 5 weeks only 1 showed 
atrophy, 4 patients shunted in the earlier group developed atrophy. There was 
no relationship shown between cerebral mantle recovery and neurological 
outcome. 
Relationship between complications and age/weight at the time of surgery 
(Table 14) 
Mortality from causes other than VP shunting are not included in this analysis. 
Shunt revisions that occurred after the initial admission period are also not 
included as they are less likely to be influenced by the timing of surgical 
intervention. 
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During their initial hospital admission nine patients had complications; either 
infection or mechanical shunt obstruction. In all cases surgical intervention 
was performed within the first month of birth. If day 35 (5 weeks) of age is 
used as a cut off then 19 patients underwent early intervention of which 9 
developed complications (47%) and 10 did not. No patients had early 
complications when surgery was performed after day 35. A comparison of the 
incidence of complications in 2 groups of patients; those undergoing surgery 
before day 35 and those having surgery after this time, shows a significantly 
higher incidence of complications in the early surgery group (x2 test p< 0.01) 
(Table 11 ). A comparison of complications occurring in patients with a birth 
weight below 1200 grams and those with a birth weight above this value 
showed no statistical correlation (x2 test p> 0.7) (Table 12). There was also no 
tendency to operate on patients at a particular time because of a certain birth 
weight (x2 test p> 0.73) (Table 13). 
Table 11 
Chi-square table comparing complications after early and late surgery 
-I 
COMPLICATIONS NONE 0 
-I 
:t> 
r 
SURGERY <35 d 9 10 19 
SURGERY >35 d 0 17 17 
TOTALS 9 27 36 
Chi-square 10.737 p-value <0.001 
Table 12 
Chi-square test comparing complications occurring below and above 
1200 grams 
-i 
COMPLICATIONS NONE 0 
-i )> 
r 
WEIGHT <1200 g 5 13 18 
WEIGHT >1200 g 4 14 18 
TOTALS 9 27 36 
Chi-square 0.148 p-value <0.7003 
Table 13 
Chi-square table comparing the timing of surgery and patient weight 
above and below 1200 grams 
WEIGHT WEIGHT 
-i 
0 
<1200 g >1200 g -i )> 
r 
SURGERY <35 d 9 10 19 
SURGERY >35 d 9 8 17 
TOTALS 18 18 36 
Chi-square 0.111 p-value < 0.7385 
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TABLE 14a 
Data for patients shunted before 5 weeks. 
# BIRTH WT IVH GRADE AGE AT SURGERY EARLY TOTAL INFEC MORTALITY DEVELOPMENT CT FINDINGS 
GRAMS IN DAYS REVISIONS REVISIONS DELAY 
800 IV 13 2 PNEUMONIA 
2 850 Ill 14 2 SEVERE RECOVERY 
3 1350 IV 14 MODERATE RECOVERY 
4 1000 Ill 14 0 KLEBS SEVERE ATROPHY 
5 1600 Ill 14 0 0 MODERATE ATROPHY 
6 1040 IV 19 0 0 
7 1250 Ill 20 1 ATROPHY 
8 1500 Ill 23 0 0 
9 1650 Ill 26 0 0 
10 1080 Ill 26 0 0 
11 1700 IV 27 0 0 RECOVERY 
12 1150 Ill 30 3 3 STAPH A SHUNT INFEC 
13 1924 Ill 30 0 0 MILD RECOVERY 
14 900 Ill 30 0 0 MILD 
15 1180 Ill 30 2 2 
16 1500 Ill 30 0 0 KLEBS SEVERE 
17 1240 I RESV 31NP93 6 6 STAPH SEVERE ATROPHY 
18 1900 IV EVD 32NP52 0 0 RECOVERY 
19 980 IV 32 0 0 
Ave 12949 24 d 
TABLE 14b 
Data for patients shunted after 5 weeks. 
# BIRTH WT IVH GRADE AGE AT SURGERY EARLY TOTAL INFEC MORTALITY DEVELOPMENT CT FINDINGS 
GRAMS IN DAYS REVISION REVISION CAUSE DELAY 
20 1110 IV 37 0 0 
21 1180 Ill 38 0 0 NORMAL RECOVERY 
22 1180 Ill 40 0 0 
23 1050 Ill 41 0 0 MINOR RECOVERY 
24 1800 IV 42 0 0 
25 1500 IV 42 0 2 SEVERE RECOVERY 
26 2100 Ill 45 0 0 SEVERE 
27 1360 IV 47 0 0 PNEUMONIA RECOVERY 
28 1140 IV 55 0 0 PNEUMONIA RECOVERY 
29 1560 57 0 0 
30 1900 62 0 0 RECOVERY 
31 740 68 0 0 SEVERE RECOVERY 
32 1800 72 0 0 
33 1120 90 0 SEVERE RECOVERY 
34 925 90 0 0 
35 840 98 0 0 SEVERE ATROPHY 
36 1350 IV 124 0 0 MINOR 
Ave 13339 62d 
IVH GRADE - According to Papile 46 
EARLY REVISION -Includes all shunts revised during the initial admission. 
INFEC. - Refers to organism cultured after proven shunt infection. 
CT FINDINGS - Refers to recovery of the cerebral mantle or atrophy as seen after shunting. 
RESV - Subcutaneous ventricular reservoir. 
EVD - External ventricular drain. 
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DISCUSSION 
The best algorithm of treatment for PHH is currently not established. A limited 
number of controlled studies with long term follow-up are reported comparing 
conservative or preventive treatment modalities such as lumbar puncture, and 
fibrinolysis 21 • 78 . None have convincingly demonstrated an improved outcome 
when used to treat this group of patients. Ultimately there are a significant 
number of patients who will require VP shunting for progressive 
hydrocephalus. 
It is unfortunate that almost all studies reporting on the outcome of VP 
shunting in PHH demonstrate a high incidence of shunt complications 
including obstruction, infection and wound breakdown 6· 13 27· 33, 35 , 38, 55, 59, 60, 61 _ 
In comparison with other reports this series has a relatively low incidence of 
complications (Table 15). To some extent this is probably as result of 
selection bias. Our neurosurgical service is remote from the surrounding 
neonatal centres and it is likely that only patients who appear to have a 
reasonable chance of survival are referred. 
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TABLE 15 
Comparison of VP shunt complications from this and other reports. 
Scarff James Lin Mccallum Levy Taylor 
et al 60 et al 27 et al 35 et al 38 et al 
33 
1983 1984 1992 1994 1997 1999 
Total number of 
shunted 20 53 27 50 47 36 
patients 
Average age at 4.5 31.5 8 26 52 42 
the time of 
weeks days weeks days days days shunting 
Number of 5 18 13 8 3 4 
shunt infections (25%) (27%) (48%) (17%) (6.3%) (11%) (%) 
Number of 
patients with 10 14 24 47 39 9 
shunt (50%) (26%) (89%) (94%) (83%) (25%) 
obstruction 
Total number of 16 23 -92 163 209 21 
revisions 
Operative 0 1 0 3 0 1 
mortality 
Follow-up 
short Nursery 9mth- 3 2-5 years Up to 16 Smth-5 period stay years years years 
Adjunctive Ventric. 1-EVD therapy prior to LP LP EVD Reservoir Tap 1- Res 
shunting 
In the results from this study it is apparent that most of the complications 
occur in the period soon after shunt insertion. Seven of the 9 patients who had 
shunt obstruction required revision during their initial hospital admission and 
all the infectious complications also occurred in this period. This finding has 
also been noted in other reports 18• 24• 26, 38, 50_ 
It is probable that along with other factors blood within the ventricles, during 
this period of haemorrhage resolution, is responsible for both shunt occlusion 
and infection. High red blood cell counts in the CSF have been shown to 
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increase the incidence of shunt obstruction 8• 55 and haemorrhage remnants in 
the ventricles probably also diminish the effectiveness of local defence 
systems 61 . 
It is for this reason that many authors have recommended various forms of 
therapy to delay the insertion of a shunt while still treating the hydrocephalus. 
However, despite the use of lumbar puncture, ventricular drains and 
reservoirs the incidence of complications remains high (Table 7). In this study 
(Taylor) a diminished complication incidence was noted when VP shunt 
insertion was delayed beyond one month. It is probable that haemorrhage 
products reach a critical level around this time and that shunt function is no 
longer compromised. This finding is supported by reports from other authors 
of higher complication rates when surgical intervention is performed at an 
early age 6• 20• 26• 38· 55 (Table16). 
TABLE 16 
Complications of VP shunts at different ages of insertion 
Study Obstruction with shunt Obstruction with shunt 
insertion < 3 weeks insertion > 3 weeks 
Boynton et al. 6 92% 60% 1986 P < 0.05 
Obstruction with shunt Obstruction with shunt 
insertion < 8 weeks insertion > 8 weeks 
Resch et al. 00 94% 44% 1989 
Obstruction with shunt Obstruction with shunt 
insertion < 5 weeks insertion > 5 weeks 
Taylor 11% 
47% 
1999 P < 0.01 
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When choosing the correct time for operative intervention surgeons must find 
a balance between early shunt insertion, in order to limit the damaging effects 
of hydrocephalus, and delaying surgery in an effort to minimise the 
complications. Despite a lack of evidence in the form of controlled trials 
randomising patients to early or late therapy for PHH most authors emphasise 
the need for early surgery 4· 6· 27• 34· 62· 76 . This position is based mostly on 
evidence of brain injury related to hydrocephalus observed in animal models 
and pathological evidence noted in adults and older children. Few clinical 
studies have demonstrated that early surgical treatment of PHH results in an 
improved outcome. 
Liechty et al concluded that CSF shunting before 6 weeks resulted in a better 
neurological outcome than after this time 34 . In this study there were 8 patients 
in either the early or late surgery group and an outcome difference between 
them was shown in psychomotor development but not mental development 
(Bayley scales of infant development). The study was flawed however in that 
patients shunted after 6 weeks were treated in the first 2 years of the trial 
when routine grading of IVH was not performed. It is possible that this group 
contained more high-grade haemorrhages and that neonatal care was not as 
advanced as later in the study. The same problem is not addressed in two 
other studies showing good outcome after early surgery 4• 17. Neither trial 
graded IVH which is the strongest predictor of outcome. Furthermore shunting 
was performed prior to one month of age when there is still a possibility that 
hydrocephalus will stabilise 16• 42• 63 . It is therefore also possible that patients 
who did not require a shunt were operated on. 
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Contrary to this, there is a large body of evidence showing that outcome is not 
altered by the timing of surgical intervention 6• 11 · 16• 33• 39 · 54· 76 . Resch et al. 
compared outcome in patients shunted before 6 weeks (n=7) and those 
shunted after 6 weeks (n=12) and showed that patients in the late surgery 
group had a better prognosis although the difference was not significant 54 . 
Boynton et al. also demonstrated that early shunting is still associated with a 
high incidence of neurodevelopmental abnormalities. Ventriculoperitoneal 
shunts were placed at a mean age of 29 days in their study and outcome 
analysis showed that 60% of patients still had multiple handicaps 6. Outcome 
data from the study presented here are insufficient to draw any conclusions 
from. Some reports have also shown worse neurological outcome after 
multiple shunt revisions and shunt infection in the treatment of PHH 54• 62 . As 
these complications are commoner after early surgery it is possible that early 
surgery may lead to a worse outcome. 
By far the strongest predictor of outcome in patients' with IVH is the grade of 
haemorrhage that is sustained 16• 28•45 . This is also true of patients who 
develop PHH with the added prognosticators of seizures, multiple shunt 
revisions and infection 6· 11 · 16· 20· 22· 24· 26• 33• 35• 38· 39· 54• 62· 76 . It is because the 
primary neurological insult of IVH has such a dominant influence on outcome 
that the role of other insults is hard to ascertain. Hydrocephalus undoubtedly 
causes secondary neurological injury but at which point this occurs or 
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becomes irreversible in the immature brain is unknown. It is possible that the 
complications of early surgical intervention have a more detrimental effect on 
the brain than early hydrocephalus. 
Evidence from this study and the literature supports the contention that 
delayed VP shunting in PHH offers the definite advantage of reduced 
complications and possible advantage of improved outcome. 
CONCLUSION 
Consideration should be given to delaying the insertion of a VP shunt until 5 
weeks of age in infants with PHH. This gives time for stabilisation and 
regression of hydrocephalus in some patients, obviating the need for surgery. 
It also allows the ventricles to clear of blood improving the chances of normal 
shunt function and limiting the occurrence of infection. Based on evidence in 
the literature this period of delay does not appear to adversely affect 
neurological outcome. 
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